A Distinct Expression of Various Gene Subsets in CD34+Cells Obtained From Patients with Early and Advanced Myelodysplastic Syndrome

被引：0

作者：

Belickova, Monika ^{[1
]}

Cermak, Jaroslav ^{[1
]}

Vasikova, Alzbeta ^{[1
]}

Budinska, Eva ^{[2
]}

机构：

[1] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic

[2] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1459 / 1460

页数：2

共 50 条

[21] Distinctive microRNA expression profiles in CD34+bone marrow cells from patients with myelodysplastic syndrome [J].

Merkerova, Michaela Dostalova ;

Krejcik, Zdenek ;

Votavova, Hana ;

Belickova, Monika ;

Vasikova, Alzbeta ;

Cermak, Jaroslav .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (03) :313-319

[22] Relative distribution of different compartments of CD34+cells in the bone marrow of patients with myelodysplastic syndromes [J].

Matarraz, S. ;

Lopez, A. ;

Salvador, C. ;

Fernandez-Mosteirin, N. ;

Giralt, M. ;

Orfao, A. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 :233-233

[23] Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome [J].

Wolf C. Prall ;

Akos Czibere ;

Franck Grall ;

Dimitrios Spentzos ;

Ulrich Steidl ;

Aristoteles Achilles Nikolaus Giagounidis ;

Andrea Kuendgen ;

Hasan Otu ;

Astrid Rong ;

Towia A. Libermann ;

Ulrich Germing ;

Norbert Gattermann ;

Rainer Haas ;

Manuel Aivado .

International Journal of Hematology, 2009, 89 :173-187

[24] Towards the lentiviral gene therapy of mobilized CD34+Cells from Fanconi anemia patients [J].

Bueren, Juan A. .

HUMAN GENE THERAPY, 2014, 25 (11) :A12-A12

[25] Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow [J].

Hofmann, WK ;

de Vos, S ;

Komor, M ;

Hoelzer, D ;

Wachsman, W ;

Koeffler, HP .

BLOOD, 2002, 100 (10) :3553-3560

[26] Phenotypic aberrations of myeloid CD34+cells in patients with myelodysplastic syndrome (MDS):: Clinical significance and correlation with cytogenetics abnormalities. [J].

Subira, D ;

Font, P ;

Arranz, E ;

Ramiro, S ;

Castanon, S ;

Renedo, M ;

Blas, C ;

Garcia, MF ;

Gonzalez, O ;

Tomas, JF ;

Fernandez-Rañada, JM .

BLOOD, 2004, 104 (11) :652A-652A

[27] Gene expression during differentiation of cord-blood Cd34+cells to eosinophils [J].

Hashida, R ;

Ogawa, K ;

Miyagawa, M ;

Sugita, Y ;

Matsumoto, K ;

Akasawa, A ;

Saito, H .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) :S32-S33

[28] Effects of Rigosertib (RIGO) Alone or in Combination with Azacitidine or Vorinostat on Epigenetic Reprogramming of CD34+Cells in the Myelodysplastic Syndrome [J].

Silverman, Lewis R. ;

Chaurasia, Pratima ;

Melana, Stella ;

Odchimar-Reissig, Rosalie ;

Demakos, Erin P. ;

Navada, Shyamala C. ;

Reddy, E. Premkumar .

BLOOD, 2017, 130

[29] Transcriptomic Evaluation of CD34+Marrow Cells from Myelodysplastic Syndrome (MDS) Patients [J].

Im, Hogune ;

Rao, Varsha ;

Sridhar, Kunju Joshi ;

Chen, Rui ;

Mias, George ;

Zhang, Yan ;

Xiao, Li ;

Snyder, Michael P. ;

Greenberg, Peter L. .

BLOOD, 2014, 124 (21)

[30] Karyotypic abnormalities in myelodysplastic syndrome do not correlate with increased number of CD34+cells in the bone marrow. [J].

Machhi, J ;

van Tuinen, P ;

Chang, C ;

Shidham, VB ;

Path, MRC ;

Eshoa, C ;

Kampalath, B .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) :650-651

← 1 2 3 4 5 →